INS and Glucose intolerance: In the present study, we found that a 4-week consecutive exposure to TBT (0.25 mg/kg) in mice caused an increase in fasting blood glucose, a decrease in plasma insulin, and an elevation in glucose intolerance accompanied by a significant increase of plasma lipid peroxidation.